---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-010498"
form_type: "8-K"
ticker: "DCTH"
cik: "0000872912"
company_name: "DELCATH SYSTEMS, INC."
filed_at: "2026-01-12T23:59:59+00:00"
generated_at: "2026-05-16T10:59:51.733029+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Delcath prelim FY2025 revenue $85.2M, HEPZATO $78.8M, cash $91M

## Summary
- Total Q4 revenue ~$20.7M, FY revenue ~$85.2M; HEPZATO KIT Q4 ~$19.0M, FY ~$78.8M.
- CHEMOSAT Q4 revenue ~$1.7M, FY ~$6.4M.
- Cash and short-term investments ~$91.0M as of Dec 31, 2025; no debt.
- 628,572 shares repurchased for $6.0M under $25M buyback program.
- 25 active sites; ~140% growth in HEPZATO procedure volume YoY; positive operating cash flow in Q4.

## SEC filing metadata
- accession: 0001193125-26-010498
- form_type: 8-K
- ticker: DCTH
- cik: 0000872912
- company_name: DELCATH SYSTEMS, INC.
- filed_at: 2026-01-12T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/872912/000119312526010498/0001193125-26-010498-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/872912/000119312526010498/d52022d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-010498
- JSON: https://secwatch.observer/filing/0001193125-26-010498.json
- Plain text: https://secwatch.observer/filing/0001193125-26-010498.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.